-+ 0.00%
-+ 0.00%
-+ 0.00%

Medpace Holdings Affirms FY2026 GAAP EPS Guidance of $16.68-$17.50 vs $17.12 Est; Affirms FY2026 Sales Guidance of $2.755B-$2.855B vs $2.808B Est

Benzinga·04/22/2026 20:21:36
Listen to the news
Medpace Holdings (NASDAQ:MEDP) affirms FY2026 GAAP EPS guidance from $16.68-$17.50 to $16.68-$17.50 vs $17.12 analyst estimate. Affirms FY2026 sales outlook from $2.755 billion-$2.855 billion to $2.755 billion-$2.855 billion vs $2.808 billion estimate.